Published on in Vol 11, No 10 (2022): October
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/37452, first published
.
![The Fetal Growth Restriction at Term Managed by Angiogenic Factors Versus Feto-Maternal Doppler (GRAFD) Trial to Avoid Adverse Perinatal Outcomes: Protocol for a Multicenter, Open-Label, Randomized Controlled Trial The Fetal Growth Restriction at Term Managed by Angiogenic Factors Versus Feto-Maternal Doppler (GRAFD) Trial to Avoid Adverse Perinatal Outcomes: Protocol for a Multicenter, Open-Label, Randomized Controlled Trial](https://asset.jmir.pub/assets/883cd0495821412070e5abfa360b2aa1.png 480w,https://asset.jmir.pub/assets/883cd0495821412070e5abfa360b2aa1.png 960w,https://asset.jmir.pub/assets/883cd0495821412070e5abfa360b2aa1.png 1920w,https://asset.jmir.pub/assets/883cd0495821412070e5abfa360b2aa1.png 2500w)
Journals
- Deinichenko O, Sіusіuka V, Krut’ Y, Pavlyuchenko M, Puchkov V, Shevchenko A, Kolokot N. Clinical and pathogenetic mechanisms of formation of fetal growth retardation. Reproductive health of woman 2023;(3):24 View
- Palmrich P, Kalafat E, Pateisky P, Schirwani‐Hartl N, Haberl C, Herrmann C, Khalil A, Binder J. Prognostic value of angiogenic markers in pregnancy with fetal growth restriction. Ultrasound in Obstetrics & Gynecology 2024;63(5):619 View